News for Midatech Pharma plc (MTPH.L)

GENEVA — The Wyss Center, a leading non-profit research center dedicated to innovating and accelerating technologies and therapies for neurological and mental…

NEW HAVEN, Conn., June 20, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | June 20, 2023

NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) —

Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLCAnnual Report 2022 ... | June 1, 2023

[210 + Pages Report] According to Zion Market Research, the global artificial saliva market size was valued at around USD 8.7 billion in 2022 and is...

Midatech Pharma Announces R&D Programme Focused on Leptomeningeal Disease

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutions put forward at general meeting, including... | March 24, 2023

THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES OF THE... | February 9, 2023

NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) —

NEW HAVEN, Conn., Feb. 03, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | February 3, 2023

NEW HAVEN, Conn., Jan. 23, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | January 23, 2023

Octopus AIM VCT 2 plc Half-Yearly Results Octopus AIM VCT 2 plc (the “Company”) is a venture capital trust (“VCT”) which aims to...

Wilmington, Delaware, United States: The pancreas is anatomically so placed that any growth here affects multiple organs like the stomach, gall bladder and intestines.

Gainers

Gainers

Octopus AIM VCT 2 plc 18 August 2021 Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc (the "Company") as at 18 August 2021 is as...

Herantis Pharma Hosts Virtual R&D Investor Day on June 8, 2021 Herantis Pharma Plc, Company release, 27 May 2021 at 8:00 AM EEST Herantis Pharma Plc , focusing on... | May 27, 2021

ABINGDON, OXFORDSHIRE / ACCESSWIRE / February 17, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has issued to .